US2005202039A1PendingUtilityA1
Renibacterium salmoninarum vaccine
Priority: Jan 30, 1997Filed: May 10, 2005Published: Sep 15, 2005
Est. expiryJan 30, 2017(expired)· nominal 20-yr term from priority
C12R 2001/06A61K 2039/552A61K 2039/522C07K 14/195C12N 1/205A61K 39/05
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides an immune stimulating agent or vaccine directed to Renibacterium salmoninarium comprising a live non-virulent culture of an Arthrobacter strain based on derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilised form with a sterile diluent.
Claims
exact text as granted — not AI-modified1 - 23 . (canceled)
24 . A method of inducing an immune response in fish comprising
administering an effective immunizing dose of an Arthrobacter species to said fish.
25 . The method of claim 24 further comprising administering an adjuvant to said fish.
26 . The method of claim 24 wherein said Arthrobacter species has a partial 16s DNA sequence that is similar to the polynucleotide sequence of SEQ ID NO: 1.
27 . The method of claim 24 wherein said Arthrobacter species has one or more of the following characteristics selected from the group consisting of (a) positive gram stain, easily discolored; (b) nonmotile; (c) in log phase growth, the cells are between approximately 0.8 and 1.2 μm by between approximately 1.0 and 8.0 μm, are often V-shaped with clubbed end; (d) as the organism approaches stationary phase, the rods segment into small cocci of approximately 0.6 to 1.0 μm in diameter; (e) catalase reaction positive; (f) oxidase reaction positive; (g) are positive to enzymatic reactions with alkaline phosphates, butyrate esterase, caprylate esterase, leucine arylamidase, trypsin, acid phosphatase, β-glucuronidase, α-glucosidase, and α-mannosidase; (h) are negative to enzymatic reactions with myristate lipase, cystine arylamidase, chymostrypsin, phosphoamidase, α-galactosidase, β-glucosidase, N-acetyl-β-glucosamidase, and α-fucosidase; and (i) are weakly positive to enzymatic reactions with valine arylamidase and β-galactosidase.
28 . The method of claim 24 wherein said Arthrobacter species has similar physical characteristics as Arthrobacter strain RSxII (ATCC Deposit Accession No ATCC 55921).
29 . The method of claim 24 wherein said Arthrobacter species is Arthrobacter strain RSxII (ATCC Deposit Accession No ATCC 55921).Join the waitlist — get patent alerts
Track US2005202039A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.